ROTOP Pharmaka GmbH – Trademark Portfolio
Entity Type: 98
ROTOP Pharmaka GmbH holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 5 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CERNT and ROTOP.
Bautzner Landstr. 400
01328 Dresden
Showing of trademarks Trademarks
Trademark Classifications
ROTOP Pharmaka GmbH's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does ROTOP Pharmaka GmbH have?
ROTOP Pharmaka GmbH has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does ROTOP Pharmaka GmbH file in?
ROTOP Pharmaka GmbH files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ROTOP Pharmaka GmbH's most well-known trademarks?
ROTOP Pharmaka GmbH's registered trademark portfolio includes well-known marks such as CERNT and ROTOP. These are among 2 currently registered trademarks in the portfolio.
What is ROTOP Pharmaka GmbH's trademark registration success rate?
ROTOP Pharmaka GmbH has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.